ADMA

Q: What is the price of ADMA Biologics (ADMA) today?

The current price of ADMA Biologics (ADMA) is $ 10.49. The stock began the year trading around $ 18.24 and is currently priced at $ 10.49. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does ADMA Biologics (ADMA) pay dividends?

ADMA Biologics (ADMA) did not pay dividends over the past year.

ADMA Biologics Inc.

Price

$ 10.49

return (12m)

p/e

17.04

p/bv

5.25

DIVIDEND YIELD

0.00%

ADMA price

ADMA Biologics

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ADMA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ADMA

review the fundamentals of ADMA Biologics shares

P/E

17.04

Sector: -4.09 Industry: -4.09

P/Receita (PSR)

4.91

Sector: -3.87 Industry: -3.87

P/BV

5.25

Sector: 1.89 Industry: 1.89

Dividend Yield (DY)

0.00%

Sector: - Industry: -

Payout

0.00%

Sector: - Industry: -

Net Profit Margins

28.80%

Sector: -39.07% Industry: -39.07%

Gross Margin

57.39%

Sector: 37.83% Industry: 37.83%

Margem Operacional

37.53%

Sector: -39.17% Industry: -39.17%

Margem EBIT

45.43%

Sector: - Industry: -

Margem EBITDA

46.90%

Sector: - Industry: -

EV/EBITDA

38.08

Sector: - Industry: -

EV/EBIT

39.31

Sector: - Industry: -

EV/EBITDA

12.65

Sector: -3.91 Industry: -3.91

EV/EBIT

13.19

Sector: -4.18 Industry: -4.18

P/Ativo

4.01

Sector: 1.39 Industry: 1.39

P/Cap Giro

6.31

Sector: - Industry: -

P/Ativo Circ Líq

7.83

Sector: - Industry: -

BVPS

2.01

Sector: 1.88 Industry: 1.88

EPS

0.62

Sector: -2.04 Industry: -2.04

Giro de Ativos

0.22

Sector: - Industry: -

ROE

30.78%

Sector: -61.00% Industry: -61.00%

ROIC

43.05%

Sector: -2,142.55% Industry: -2,142.55%

ROA

23.54%

Sector: -61.28% Industry: -61.28%

Dívida Líquida / Patrimônio

-0.04

Sector: - Industry: -

Dívida Líquida / EBITDA

-0.28

Sector: - Industry: -

Dívida Líquida / EBIT

-0.29

Sector: - Industry: -

Dívida Bruta / Patrimônio

0.15

Sector: - Industry: -

Patrimônio / Ativos

0.76

Sector: 0.42 Industry: 0.42

Passivos / Ativos

0.24

Sector: 0.38 Industry: 0.38

Liquidez Corrente

6.71

Sector: - Industry: -

CAGR Receitas 5 Anos

64.44%

Sector: - Industry: -

CAGR Lucros 5 Anos

0.00%

Sector: - Industry: -

FAIR VALUE OF ADMA Biologics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$10.49

Fair Value

$5.30

Upside/Downside Return potential.

-49.52%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ADMA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ADMA	17.04	5.25	30.78%	0.00%	$2.50 B	28.80%
AZN	27.54	6.04	21.93%	1.73%	$286.16 B	17.19%
JNJ	26.01	6.74	25.92%	2.29%	$547.30 B	21.83%
NBIX	27.51	4.05	14.71%	0.00%	$13.17 B	16.73%
ABEO	4.20	1.88	44.71%	0.00%	$298.65 M	100.00%
PFE	19.27	1.61	8.35%	6.53%	$149.71 B	12.42%
ABBV	100.54	0.00	0.00%	3.22%	$365.48 B	5.79%
ACAD	9.54	3.04	31.86%	0.00%	$3.73 B	36.49%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ADMA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ADMA Biologics

ADMA Biologics Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

22 years

Founded: 2004

2013

Time since IPO - 13 years

407

Employees

ADMA Biologics Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $2.50 billion, with shareholders equity totaling $477.32 million.

The company employs approximately 407 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, ADMA Biologics Inc. reported $510.16 million in revenue, generating net income of $146.93 million.

Key financial metrics include a P/E ratio of 17.04, a price-to-book (P/B) ratio of 5.25, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ADMA.

Market cap

$2.50 billion

Net worth

$477.32 million

$ 477,320,000.00

Assets

$624.24 million

$ 624,240,000.00

Total Shares Outstanding

238.00 million

238,000,000

Average Daily Trading Volume

$6.93 million

$ 6,930,016.00

Sector

Healthcare

Industry

Biotecnologia

ADMA

ADMA revenue and profits

Financial Results ADMA

DRAG THE FRAME TO SEE MORE DATA

ADMA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 21,75% (12M)

P/E

23.07

0.39%

ROE

-4,383.84%

P/BV

-1,011.36

CAH - Cardinal Health

$214.95 41,04% (12M)

P/E

29.51

1.05%

ROE

-58.20%

P/BV

-17.17

JNJ - Johnson & Johnson

$240.16 60,65% (12M)

P/E

26.01

2.29%

ROE

25.92%

P/BV

6.74

PFE - Pfizer

$27.11 25,77% (12M)

P/E

19.27

6.53%

ROE

8.35%

P/BV

1.61

MRK - Merck & Co.

$119.96 60,16% (12M)

P/E

31.01

2.96%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$204.64 42,91% (12M)

P/E

27.54

1.73%

ROE

21.93%

P/BV

6.04

ABBV - AbbVie

$210.26 15,72% (12M)

P/E

100.54

3.22%

ROE

0.00%

P/BV

0.00

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$862.96 21,75% (12 M)

P/L

23.07

0.39%

ROE

-4,383.84%

P/VP

-1,011.36

CAH - Cardinal Health

$214.95 41,04% (12 M)

P/L

29.51

1.05%

ROE

-58.20%

P/VP

-17.17

JNJ - Johnson & Johnson

$240.16 60,65% (12 M)

P/L

26.01

2.29%

ROE

25.92%

P/VP

6.74

PFE - Pfizer

$27.11 25,77% (12 M)

P/L

19.27

6.53%

ROE

8.35%

P/VP

1.61

MRK - Merck & Co.

$119.96 60,16% (12 M)

P/L

31.01

2.96%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$204.64 42,91% (12 M)

P/L

27.54

1.73%

ROE

21.93%

P/VP

6.04

ABBV - AbbVie

$210.26 15,72% (12 M)

P/L

100.54

3.22%

ROE

0.00%

P/VP

0.00

Frequently Asked Questions

What is the price of ADMA Biologics (ADMA) today?

The current price of ADMA Biologics (ADMA) is $ 10.49. The stock began the year trading around $ 18.24 and is currently priced at $ 10.49. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does ADMA Biologics (ADMA) pay dividends?

ADMA Biologics (ADMA) did not pay dividends over the past year.

Is ADMA Biologics (ADMA) a good investment?

ADMA Biologics (ADMA) is currently trading at $ 10.49 with a P/E ratio of 17.04. This represents a -248% premium compared to its historical average P/E. Over the past year, the stock paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ADMA Biologics (ADMA) stock?

You can buy ADMA Biologics (ADMA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ADMA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of ADMA Biologics (ADMA) yield today?

Over the past month, ADMA Biologics (ADMA) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of ADMA Biologics (ADMA) today at the current price of $ 10.49 your total investment would be $ 1,049.00.

Based on historical performance, the investment would have grown to approximately:

$ 1,049.00 after 1 year
$ 1,049.00 after 5 years
$ 1,049.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ADMA

ADMA Biologics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ADMA

review the fundamentals of ADMA Biologics shares

P/E

P/Receita (PSR)

P/BV

Dividend Yield (DY)

Payout

Net Profit Margins

Gross Margin

Margem Operacional

Margem EBIT

Margem EBITDA

EV/EBITDA

EV/EBIT

EV/EBITDA

EV/EBIT

P/Ativo

P/Cap Giro

P/Ativo Circ Líq

BVPS

EPS

Giro de Ativos

ROE

ROIC

ROA

Dívida Líquida / Patrimônio

Dívida Líquida / EBITDA

Dívida Líquida / EBIT

Dívida Bruta / Patrimônio

Patrimônio / Ativos

Passivos / Ativos

Liquidez Corrente

CAGR Receitas 5 Anos

CAGR Lucros 5 Anos

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ADMA Biologics Inc.

States of America

22 years

2013

407

PROFIT X PRICE ADMA

Financial Results ADMA

ADMA cash flow

Asset, Revenue and Profit Growth - ADMA

ADMA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

Frequently Asked Questions